# DIGOXIN

NDC: 51662-1217
Generic name: DIGOXIN
Labeler / Manufacturer: HF Acquisition Co LLC, DBA HealthFirst
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAMUSCULAR, INTRAVENOUS
Marketing started: 20180913

FDA application: ANDA083391

## Active ingredients

- DIGOXIN: .25 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"51662-1217"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=51662-1217
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=75c99fc4-33b6-c3ce-e053-2991aa0a4d88